Gaush Meditech Ltd (HKG:2407)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.500
-0.060 (-1.32%)
Oct 2, 2026, 3:55 PM HKT

Gaush Meditech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
75.4996.1992.39173.52-349.62-190.45
Depreciation & Amortization
89.0189.2680.674.6964.6358.84
Other Amortization
1.61.61.341.281.121.22
Loss (Gain) From Sale of Assets
00.090.68-0.150.670.05
Asset Writedown & Restructuring Costs
2.362.3623.26---
Loss (Gain) From Sale of Investments
3.15-2.81-3.72-3.96-0.01-0.09
Provision & Write-off of Bad Debts
-1.63-0.44-0.56-1.24-2.244.76
Other Operating Activities
-44.62-31.9117.2333.51501.67365.18
Change in Accounts Receivable
20.575.33-16.4319.688.2620.49
Change in Inventory
25.05-5.68-5.11-48.74-41.7838.59
Change in Accounts Payable
-0.9410.21-19.6722.1-4.18-42.57
Change in Unearned Revenue
19.110.69-21.71-7.5139.8-27.6
Change in Other Net Operating Assets
-25.17-20.66-40.53-14.14-4.86-68.64
Operating Cash Flow
163.99144.23107.78249.04234.42164.49
Operating Cash Flow Growth
15.04%33.82%-56.72%6.24%42.52%26.53%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-23.96-22.77-14.67-34.92-45.4-26.55
Sale of Property, Plant & Equipment
0.020.0100.01--
Cash Acquisitions
-0.93-2.78-23.79-9.4-105.77
Sale (Purchase) of Intangibles
-14.86-10.99-66.55-10.67-2.62-1.5
Investment in Securities
4.5197.6280.19-81.11-92.7-
Other Investing Activities
-17.85-40.2743.35-31.554.682.11
Investing Cash Flow
-53.0720.8218.55-167.65-136.0479.84

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-82.8127.527.9257.7266.08
Long-Term Debt Repaid
--209.73-135.56-153.08-339.94-104.96
Lease Payments
-23.66-26.05-25.87-22.27-23.63-14.41
Net Debt Issued (Repaid)
-72.42-126.92-108.04-145.16-282.21-38.88
Issuance of Common Stock
---1.55327.829.07
Repurchase of Common Stock
-23.18-24.58-12.58---489.73
Common Dividends Paid
-39.78-39.78-148.56---
Other Financing Activities
-8.55-15.33-33.93-46.32-42.51-86.73
Financing Cash Flow
-143.93-206.6-303.09-189.943.0872.84

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
10.1341.12-20.55.7211.07-15.66
Net Cash Flow
-22.88-0.43-197.26-102.83112.53301.51

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
140.03121.4693.12214.11189.03137.94
Free Cash Flow Growth
11.88%30.44%-56.51%13.27%37.04%7.57%
Free Cash Flow Margin
10.59%8.80%6.52%15.23%15.08%10.63%
Free Cash Flow Per Share
0.970.840.631.451.951.44
Levered Free Cash Flow
76.9783.19-7.59123.94137.2-9.58
Unlevered Free Cash Flow
86.6695.4415.35155.56163.8742.63
Free Cash Flow After Leases
116.3795.4267.25191.85165.4123.53

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13.3417.3733.3842.2738.8276.09
Cash Income Tax Paid
78.2972.9489.7185.4794.4997.43
Change in Working Capital
38.63-10.11-103.44-28.62-2.76-79.74